Literature DB >> 25748326

Using Amplicon Deep Sequencing to Detect Genetic Signatures of Plasmodium vivax Relapse.

Jessica T Lin1, Nicholas J Hathaway2, David L Saunders3, Chanthap Lon3, Sujata Balasubramanian1, Oksana Kharabora1, Panita Gosi3, Sabaithip Sriwichai3, Laurel Kartchner4, Char Meng Chuor5, Prom Satharath6, Charlotte Lanteri3, Jeffrey A Bailey7, Jonathan J Juliano1.   

Abstract

Plasmodium vivax infections often recur due to relapse of hypnozoites from the liver. In malaria-endemic areas, tools to distinguish relapse from reinfection are needed. We applied amplicon deep sequencing to P. vivax isolates from 78 Cambodian volunteers, nearly one-third of whom suffered recurrence at a median of 68 days. Deep sequencing at a highly variable region of the P. vivax merozoite surface protein 1 gene revealed impressive diversity-generating 67 unique haplotypes and detecting on average 3.6 cocirculating parasite clones within individuals, compared to 2.1 clones detected by a combination of 3 microsatellite markers. This diversity enabled a scheme to classify over half of recurrences as probable relapses based on the low probability of reinfection by multiple recurring variants. In areas of high P. vivax diversity, targeted deep sequencing can help detect genetic signatures of relapse, key to evaluating antivivax interventions and achieving a better understanding of relapse-reinfection epidemiology.
© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Plasmodium vivax; amplicon sequencing; deep sequencing; genetic diversity; hypnozoite; malaria; microsatellite; multiplicity of infection; pvmsp1; relapse

Mesh:

Substances:

Year:  2015        PMID: 25748326      PMCID: PMC4548463          DOI: 10.1093/infdis/jiv142

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  41 in total

1.  Estimating true antimalarial efficacy by heteroduplex tracking assay in patients with complex Plasmodium falciparum infections.

Authors:  Jesse J Kwiek; Alisa P Alker; Emily C Wenink; Marjorie Chaponda; Linda V Kalilani; Steven R Meshnick
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

2.  Higher microsatellite diversity in Plasmodium vivax than in sympatric Plasmodium falciparum populations in Pursat, Western Cambodia.

Authors:  Pamela Orjuela-Sánchez; Juliana M Sá; Michelle C C Brandi; Priscila T Rodrigues; Melissa S Bastos; Chanaki Amaratunga; Socheat Duong; Rick M Fairhurst; Marcelo U Ferreira
Journal:  Exp Parasitol       Date:  2013-04-04       Impact factor: 2.011

Review 3.  Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels.

Authors:  J K Baird; B Leksana; S Masbar; D J Fryauff; M A Sutanihardja; F S Wignall; S L Hoffman
Journal:  Am J Trop Med Hyg       Date:  1997-06       Impact factor: 2.345

4.  Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites.

Authors:  Mallika Imwong; Georges Snounou; Sasithon Pukrittayakamee; Naowarat Tanomsing; Jung Ryong Kim; Amitab Nandy; Jean-Paul Guthmann; Francois Nosten; Jane Carlton; Sornchai Looareesuwan; Shalini Nair; Daniel Sudimack; Nicholas P J Day; Timothy J C Anderson; Nicholas J White
Journal:  J Infect Dis       Date:  2007-02-26       Impact factor: 5.226

5.  Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia.

Authors:  Inge Sutanto; Bagus Tjahjono; Hasan Basri; W Robert Taylor; Fauziah A Putri; Rizka A Meilia; Rianto Setiabudy; Siti Nurleila; Lenny L Ekawati; Iqbal Elyazar; Jeremy Farrar; Herawati Sudoyo; J Kevin Baird
Journal:  Antimicrob Agents Chemother       Date:  2012-12-17       Impact factor: 5.191

6.  Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1-5 years of age.

Authors:  Inoni Betuela; Anna Rosanas-Urgell; Benson Kiniboro; Danielle I Stanisic; Lornah Samol; Elisa de Lazzari; Hernando A Del Portillo; Peter Siba; Pedro L Alonso; Quique Bassat; Ivo Mueller
Journal:  J Infect Dis       Date:  2012-09-10       Impact factor: 5.226

7.  The first Plasmodium vivax relapses of life are usually genetically homologous.

Authors:  Mallika Imwong; Machteld E Boel; Watcharee Pagornrat; Mupawjay Pimanpanarak; Rose McGready; Nicholas P J Day; François Nosten; Nicholas J White
Journal:  J Infect Dis       Date:  2011-12-22       Impact factor: 5.226

8.  Genotyping of Plasmodium vivax reveals both short and long latency relapse patterns in Kolkata.

Authors:  Jung-Ryong Kim; Amitabha Nandy; Ardhendu Kumar Maji; Manjulika Addy; Arjen M Dondorp; Nicholas P J Day; Sasithon Pukrittayakamee; Nicholas J White; Mallika Imwong
Journal:  PLoS One       Date:  2012-07-13       Impact factor: 3.240

9.  Close kinship within multiple-genotype malaria parasite infections.

Authors:  Standwell C Nkhoma; Shalini Nair; Ian H Cheeseman; Cherise Rohr-Allegrini; Sittaporn Singlam; François Nosten; Tim J C Anderson
Journal:  Proc Biol Sci       Date:  2012-03-07       Impact factor: 5.349

10.  Multiple-clone activation of hypnozoites is the leading cause of relapse in Plasmodium vivax infection.

Authors:  Flávia Carolina F de Araujo; Antônio Mauro de Rezende; Cor Jesus F Fontes; Luzia Helena Carvalho; Cristiana F Alves de Brito
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

View more
  41 in total

Review 1.  The utility of genomic data for Plasmodium vivax population surveillance.

Authors:  Rachel F Daniels; Benjamin L Rice; Noah M Daniels; Sarah K Volkman; Daniel L Hartl
Journal:  Pathog Glob Health       Date:  2015-04-18       Impact factor: 2.894

2.  Non-falciparum Malaria in Africa and Learning From Plasmodium vivax in Asia.

Authors:  Jessica T Lin; Jonathan B Parr; Billy Ngasala
Journal:  Clin Infect Dis       Date:  2020-04-15       Impact factor: 9.079

3.  Selective sweep suggests transcriptional regulation may underlie Plasmodium vivax resilience to malaria control measures in Cambodia.

Authors:  Christian M Parobek; Jessica T Lin; David L Saunders; Eric J Barnett; Chanthap Lon; Charlotte A Lanteri; Sujata Balasubramanian; Nicholas Brazeau; Derrick K DeConti; Deen L Garba; Steven R Meshnick; Michele D Spring; Char Meng Chuor; Jeffrey A Bailey; Jonathan J Juliano
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-28       Impact factor: 11.205

4.  Plasmodium falciparum msp1 and msp2 genetic diversity in parasites isolated from symptomatic and asymptomatic malaria subjects in the South of Benin.

Authors:  Hamirath Odée Lagnika; Azizath Moussiliou; Romuald Agonhossou; Pierre Sovegnon; Oswald Yédjinnavênan Djihinto; Adandé Assogba Medjigbodo; Laurette Djossou; Linda Eva Amoah; Aurore Ogouyemi-Hounto; Luc Salako Djogbenou
Journal:  Parasitol Res       Date:  2022-01-06       Impact factor: 2.289

5.  Efficient Transmission of Mixed Plasmodium falciparum/vivax Infections From Humans to Mosquitoes.

Authors:  Sujata Balasubramanian; Rifat S Rahman; Chanthap Lon; Christian Parobek; Ratawan Ubalee; Nicholas Hathaway; Worachet Kuntawunginn; Mok My; Dav Vy; Jeremy Saxe; Charlotte Lanteri; Feng-Chang Lin; Michele Spring; Steven R Meshnick; Jonathan J Juliano; David L Saunders; Jessica T Lin
Journal:  J Infect Dis       Date:  2020-01-14       Impact factor: 5.226

6.  Efficacy of Chloroquine and Primaquine for the Treatment of Uncomplicated Plasmodium vivax Malaria in Cruzeiro do Sul, Brazil.

Authors:  Suiane Negreiros; Samela Farias; Giselle Maria Rachid Viana; Sheila Akinyi Okoth; Stella M Chenet; Thayna Maria Holanda de Souza; Paola Marchesini; Venkatachalam Udhayakumar; Marinete Marins Povoa; Ana Carolina Faria E Silva Santelli; Alexandre Macedo de Oliveira
Journal:  Am J Trop Med Hyg       Date:  2016-08-22       Impact factor: 2.345

7.  Pooled Amplicon Deep Sequencing of Candidate Plasmodium falciparum Transmission-Blocking Vaccine Antigens.

Authors:  Jonathan J Juliano; Christian M Parobek; Nicholas F Brazeau; Billy Ngasala; Milijaona Randrianarivelojosia; Chanthap Lon; Kashamuka Mwandagalirwa; Antoinette Tshefu; Ravi Dhar; Bidyut K Das; Irving Hoffman; Francis Martinson; Andreas Mårtensson; David L Saunders; Nirbhay Kumar; Steven R Meshnick
Journal:  Am J Trop Med Hyg       Date:  2015-10-26       Impact factor: 2.345

Review 8.  Malaria Epidemiology at the Clone Level.

Authors:  Cristian Koepfli; Ivo Mueller
Journal:  Trends Parasitol       Date:  2017-09-28

9.  Recrudescence, Reinfection, or Relapse? A More Rigorous Framework to Assess Chloroquine Efficacy for Plasmodium vivax Malaria.

Authors:  Jean Popovici; Lindsey Pierce-Friedrich; Saorin Kim; Sophalai Bin; Vorleak Run; Dysoley Lek; Kim Hor Daryl Hee; Lawrence Lee Soon-U; Matthew V Cannon; David Serre; Didier Menard
Journal:  J Infect Dis       Date:  2019-01-07       Impact factor: 5.226

10.  Relapse or reinfection: Classification of malaria infection using transition likelihoods.

Authors:  Feng-Chang Lin; Quefeng Li; Jessica T Lin
Journal:  Biometrics       Date:  2020-03-03       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.